financetom
Business
financetom
/
Business
/
Hanesbrands Shares Rise After Fiscal Q2 Results Beat Expectations, 2025 Outlook Raised
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hanesbrands Shares Rise After Fiscal Q2 Results Beat Expectations, 2025 Outlook Raised
Aug 7, 2025 7:18 AM

09:51 AM EDT, 08/07/2025 (MT Newswires) -- Hanesbrands ( HBI ) shares were up 20% early Thursday after the company reported improved fiscal Q2 results that beat expectations and raised its full-year outlook.

The company reported Q2 adjusted earnings from continuing operations of $0.24 per diluted share, up from $0.15 a year earlier.

Analysts polled by FactSet expected $0.18.

Net sales for the quarter ended June 28 were $991.3 million, up from $973.9 million a year earlier.

Analysts surveyed by FactSet expected $968.2 million.

For fiscal Q3, the company said it expects adjusted EPS from continuing operations of about $0.16 on net sales of about $900 million. Analysts polled by FactSet expect $0.14 on $891.8 million in sales.

For 2025, the company raised its adjusted EPS guidance from continuing operations of $0.66 from its prior outlook of $0.51 to $0.55. Analysts surveyed by FactSet expect $0.54.

Net sales for the fiscal year are expected to be about $3.53 billion compared with the previous outlook of $3.47 billion to $3.52 billion. Analysts polled by FactSet expect $3.48 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Achieve Life Sciences' Cytisinicline Gets US FDA's Breakthrough Therapy Designation
Achieve Life Sciences' Cytisinicline Gets US FDA's Breakthrough Therapy Designation
Jul 31, 2024
02:06 PM EDT, 07/31/2024 (MT Newswires) -- Achieve Life Sciences ( ACHV ) got the US Food and Drug Administration's Breakthrough Therapy Designation for cytisinicline to treat for e-cigarette or vaping nicotine dependence. The designation is based on results from the phase 2 trial that showed treatment with cytisinicline more than doubled the odds of quitting e-cigarettes compared with placebo,...
Market Chatter: Disney Plans New Round of Job Cuts in Television Division
Market Chatter: Disney Plans New Round of Job Cuts in Television Division
Jul 31, 2024
02:10 PM EDT, 07/31/2024 (MT Newswires) -- Walt Disney ( DIS ) is planning to eliminate about 140 jobs, or 2% of its staff, at Disney Entertainment Television, Bloomberg reported Wednesday, citing people with knowledge of the matter. The cuts will impact the NatGeo and Freeform networks the most, as well as ABC stations, Bloomberg reported. (Market Chatter news is...
Tesla was in Full Self-Driving mode when it hit and killed Seattle motorcylist, police say
Tesla was in Full Self-Driving mode when it hit and killed Seattle motorcylist, police say
Jul 31, 2024
SAN FRANCISCO (Reuters) - A Tesla Model S car was in Full Self-Driving mode when it hit and killed a 28-year-old motorcyclist in the Seattle area in April, police said, making it at least the second accident involving the technology on which Tesla CEO Elon Musk is pinning his hopes. The 56-year-old driver was arrested on suspicion of vehicular homicide...
US agency stands by decision 51 million air bag inflators pose safety risks
US agency stands by decision 51 million air bag inflators pose safety risks
Jul 31, 2024
WASHINGTON (Reuters) - The National Highway Traffic Safety Administration said Wednesday it was standing by its initial decision that 51 million air bag inflators in 49 million U.S. vehicles built by 13 automakers pose serious safety risks. NHTSA argued at a hearing in October that inflators produced by the two air bag manufacturers, ARC Automotive and Delphi Automotive, should be...
Copyright 2023-2026 - www.financetom.com All Rights Reserved